companies / gateway-bio-inc
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-21 json
| total_raised | 1,300,0001.3M | ○ |
|---|---|---|
| founded | null | |
| hq | durham, nc, usa | |
| industry | unknown | |
| stage | null |
Gateway Bio is a biotechnology company focused on translational drug development across early-stage pipeline assets. Public information is limited; the company is positioned in the broader therapeutics space. The web presence does not currently advertise specific platforms.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 1,300,0001.3M | null | ○ |
| fact | status | src |
|---|---|---|
| Grant, $1.3M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |